• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    4/3/23 1:36:59 PM ET
    $ADV
    $AGLE
    $ALLR
    $ALRN
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADV alert in real time by email

     

    On Monday, 76 companies set new 52-week lows.

    Facts of Interest About Today's 52-Week Lows:

    • CVB Financial (NASDAQ:CVBF) was the biggest company in terms of market cap to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest firm by market cap to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX)'s stock moved significantly downwards, trading down 25.64% to reach a new 52-week low.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Monday:

    • CVB Financial (NASDAQ:CVBF) shares made a new 52-week low of $16.33 on Monday. The stock was down 1.78% for the day.
    • Semtech (NASDAQ:SMTC) stock drifted down 4.73% on Monday morning to hit a new 52-week low of $22.83.
    • Westamerica Bancorp (NASDAQ:WABC) shares fell to $43.21 on Monday, setting a new 52-week low with a shift of down 2.13%.
    • Canopy Gwth (NASDAQ:CGC) stock set a new 52-week low of $1.70 on Monday, moving down 2.57%.
    • Twist Bioscience (NASDAQ:TWST) shares moved down 7.69% on Monday to hit a new 52-week low of $13.89, drifting down 7.69%.
    • Advantage Solutions (NASDAQ:ADV) stock achieved a new 52-week low on Monday morning, hitting $1.54 and moving up 7.59%.
    • Northfield Bancorp (NASDAQ:NFBK) stock broke to a new 52-week low of $11.59 on Monday. Shares of the company traded down 0.93%.
    • Sharecare (NASDAQ:SHCR) shares set a new yearly low of $1.32 this morning. The stock was down 5.99% on the session.
    • Southern Missouri Bancorp (NASDAQ:SMBC) stock dropped to a yearly low on Monday of $36.86. Shares traded down 1.06%.
    • First Community (NASDAQ:FCBC) shares were down 0.02% for the day, having made a 52-week low of $24.73.
    • Bank of Marin (NASDAQ:BMRC) shares made a new 52-week low of $21.30 on Monday. The stock was down 2.38% for the day.
    • Guaranty Bancshares (NYSE:GNTY) stock hit $26.56 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Nano X Imaging (NASDAQ:NNOX) stock dropped to a yearly low on Monday of $5.49. Shares traded down 4.51%.
    • Summit Finl Gr (NASDAQ:SMMF) stock drifted down 1.06% on Monday morning to hit a new 52-week low of $20.34.
    • Sierra (NASDAQ:BSRR) stock drifted down 1.8% on Monday morning to hit a new 52-week low of $16.87.
    • MVB Financial (NASDAQ:MVBF) stock set a new 52-week low of $19.86 on Monday, moving down 2.37%.
    • Southern First Bancshares (NASDAQ:SFST) shares made a new 52-week low of $29.87 on Monday. The stock was down 1.99% for the day.
    • Kezar Life Sciences (NASDAQ:KZR) stock dropped to a yearly low on Monday of $3.08. Shares traded down 0.96%.
    • BayCom (NASDAQ:BCML) shares were down 2.69% for the day, having made a 52-week low of $16.59.
    • Inovio Pharmaceuticals (NASDAQ:INO) shares set a new 52-week low of $0.77. The stock traded down 5.09%.
    • Satellogic (NASDAQ:SATL) shares fell to $2.10 on Monday, setting a new 52-week low with a shift of down 0.47%.
    • ALX Oncology Holdings (NASDAQ:ALXO) stock set a new 52-week low of $4.43 on Monday, moving down 0.22%.
    • First Guaranty Bancshares (NASDAQ:FGBI) stock hit $14.08 on Monday morning, setting a new 52-week low for a change of down 7.34%.
    • Wheels Up Experience (NYSE:UP) stock hit a new 52-week low of $0.58. The stock was down 5.18% on the session.
    • First Internet (NASDAQ:INBK) stock achieved a new 52-week low on Monday morning, hitting $16.10 and moving down 3.3%.
    • FLJ Group (NASDAQ:FLJ) stock set a new 52-week low of $0.70 on Monday, moving down 3.56%.
    • YS Biopharma Co (NASDAQ:YS) shares moved down 10.63% on Monday to hit a new 52-week low of $1.40, drifting down 10.63%.
    • Veru (NASDAQ:VERU) stock achieved a new 52-week low on Monday morning, hitting $1.13 and moving down 1.72%.
    • Vinco Ventures (NASDAQ:BBIG) stock dropped to a yearly low on Monday of $0.30. Shares traded down 5.51%.
    • Movella Holdings (NASDAQ:MVLA) stock drifted down 6.62% on Monday morning to hit a new 52-week low of $1.26.
    • Snail (NASDAQ:SNAL) shares hit a yearly low of $1.24. The stock was down 3.28% on the session.
    • Bed Bath & Beyond (NASDAQ:BBBY) stock dropped to a yearly low on Monday of $0.37. Shares traded down 10.32%.
    • Hongli Group (NASDAQ:HLP) shares reached a new 52-week low of $3.25 on Monday morning, moving up 1.44%.
    • Rubicon Technologies (NYSE:RBT) shares hit a yearly low of $0.50. The stock was down 17.08% on the session.
    • Foresight Autonomous (NASDAQ:FRSX) stock hit a yearly low of $0.40. The stock was down 0.73% for the day.
    • Appreciate Holdings (NASDAQ:SFR) shares were down 5.7% for the day, having made a 52-week low of $0.51.
    • Chanson International (NASDAQ:CHSN) shares were down 15.17% for the day, having made a 52-week low of $1.69.
    • Unity Biotechnology (NASDAQ:UBX) stock hit a yearly low of $1.54. The stock was down 3.67% for the day.
    • Beamr Imaging (NASDAQ:BMR) shares moved down 13.07% on Monday to hit a new 52-week low of $1.71, drifting down 13.07%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.85 on Monday, setting a new 52-week low with a shift of down 6.38%.
    • ICZOOM Group (NASDAQ:IZM) stock achieved a new 52-week low on Monday morning, hitting $1.69 and moving up 6.94%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares reached a new 52-week low of $0.28 on Monday morning, moving 0.0% (flat).
    • Trinity Place Hldgs (AMEX:TPHS) shares set a new 52-week low of $0.44. The stock traded down 4.17%.
    • Micromobility com (NASDAQ:MCOM) stock broke to a new 52-week low of $2.72 on Monday. Shares of the company traded down 24.86%.
    • Aprea Therapeutics (NASDAQ:APRE) shares made a new 52-week low of $4.28 on Monday. The stock was down 3.6% for the day.
    • Microbot Medical (NASDAQ:MBOT) stock drifted down 5.03% on Monday morning to hit a new 52-week low of $1.91.
    • Asset Entities (NASDAQ:ASST) shares set a new 52-week low of $1.09. The stock traded down 13.85%.
    • Generation Income (NASDAQ:GIPR) shares fell to $4.47 on Monday, setting a new 52-week low with a shift of up 3.78%.
    • Coffee Holding Co (NASDAQ:JVA) shares set a new yearly low of $1.73 this morning. The stock was down 4.36% on the session.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) stock set a new 52-week low of $0.15 on Monday, moving down 17.86%.
    • Imunon (NASDAQ:IMNN) shares moved down 0.49% on Monday to hit a new 52-week low of $1.21, drifting down 0.49%.
    • Cyclo Therapeutics (NASDAQ:CYTH) stock achieved a new 52-week low on Monday morning, hitting $0.80 and moving up 1.18%.
    • Auddia (NASDAQ:AUUD) shares moved down 5.35% on Monday to hit a new 52-week low of $0.67, drifting down 5.35%.
    • Redhill Biopharma (NASDAQ:RDHL) stock broke to a new 52-week low of $3.71 on Monday. Shares of the company traded down 7.58%.
    • Diffusion Pharmaceuticals (NASDAQ:DFFN) shares reached a new 52-week low of $3.80 on Monday morning, moving down 1.22%.
    • XORTX Therapeutics (NASDAQ:XRTX) shares set a new yearly low of $0.42 this morning. The stock was down 3.25% on the session.
    • Ensysce Biosciences (NASDAQ:ENSC) shares moved down 7.61% on Monday to hit a new 52-week low of $4.45, drifting down 7.61%.
    • Aileron Therapeutics (NASDAQ:ALRN) stock set a new 52-week low of $1.21 on Monday, moving down 2.42%.
    • Codiak BioSciences (NASDAQ:CDAK) stock dropped to a yearly low on Monday of $0.13. Shares traded down 14.67%.
    • Cryptyde (NASDAQ:TYDE) shares reached a new 52-week low of $0.07 on Monday morning, moving down 9.98%.
    • SINTX Technologies (NASDAQ:SINT) stock hit $1.84 on Monday morning, setting a new 52-week low for a change of down 8.78%.
    • Minim (NASDAQ:MINM) stock hit $0.08 on Monday morning, setting a new 52-week low for a change of down 20.75%.
    • Tenax Therapeutics (NASDAQ:TENX) shares reached a new 52-week low of $0.41 on Monday morning, moving down 9.68%.
    • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock achieved a new 52-week low on Monday morning, hitting $0.64 and moving down 1.26%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares set a new yearly low of $1.63 this morning. The stock was up 18.27% on the session.
    • G Medical Innovations (NASDAQ:GMVD) shares hit a yearly low of $0.71. The stock was down 19.78% on the session.
    • CNS Pharmaceuticals (NASDAQ:CNSP) shares fell to $0.92 on Monday, setting a new 52-week low with a shift of 0.0% (flat).
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 25.64% for the day, having made a 52-week low of $0.29.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ADV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADV
    $AGLE
    $ALLR
    $ALRN

    CompanyDatePrice TargetRatingAnalyst
    Satellogic Inc.
    $SATL
    2/20/2026$7.00Overweight
    Cantor Fitzgerald
    Satellogic Inc.
    $SATL
    2/18/2026$5.50Outperform
    Northland Capital
    MVB Financial Corp.
    $MVBF
    2/13/2026$31.00 → $33.00Outperform
    Hovde Group
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    First Internet Bancorp
    $INBK
    1/30/2026$26.00 → $29.00Outperform
    Hovde Group
    Satellogic Inc.
    $SATL
    1/21/2026$5.00Buy
    Craig Hallum
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Microbot Medical Inc.
    $MBOT
    12/3/2025$5.50Buy
    Roth Capital
    More analyst ratings

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Satellogic with a new price target

    Cantor Fitzgerald initiated coverage of Satellogic with a rating of Overweight and set a new price target of $7.00

    2/20/26 8:25:25 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Northland Capital initiated coverage on Satellogic with a new price target

    Northland Capital initiated coverage of Satellogic with a rating of Outperform and set a new price target of $5.50

    2/18/26 7:54:52 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Hovde Group reiterated coverage on MVB Financial with a new price target

    Hovde Group reiterated coverage of MVB Financial with a rating of Outperform and set a new price target of $33.00 from $31.00 previously

    2/13/26 7:59:44 AM ET
    $MVBF
    Major Banks
    Finance

    $ADV
    $AGLE
    $ALLR
    $ALRN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    March 26, 2021 - Coronavirus (COVID-19) Update: March 26, 2021

    For Immediate Release: March 26, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On March 23, 2021, the FDA issued an emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay. The SARS-CoV-2 NGS Assay is a next-generation sequencing (NGS) based test for the identification of SARS-CoV-2 RNA from respirato

    3/26/21 3:51:09 PM ET
    $TWST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

    DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational validation, positioning themselves for potential continued follow-through. From biomaterials scale-up to enterprise AI deployment and disciplined capital allocation, these names are building narratives that extend beyond a single news cycle. Kraig Biocraft Laboratories: From Strategy to Scale Activity has accelerated at Kraig Biocraft Laboratories (OTCQB:KBLB) following confirmation that its 2026 production plan has officially transitioned from roadmap to execution. The company has moved bio

    2/27/26 9:45:46 AM ET
    $ENSC
    $PLTR
    $RXT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    - Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains on track following strong 2025 execution; company anticipates multiple meaningful data sets and milestones in the coming 12 to 18 months - - Evorpacept biomarker strategy validated by data from both the Phase 2 ASPEN-06 gastric cancer trial and the Phase 1b/2 breast cancer trial, independently suggesting CD47 overexpression is predictive of evorpacept activity and drives durable benefit in HER2-positive cancers - - Full biomarker analysis from Phase 1b/2 evorpacept-zanidatamab combination trial accepted for poster presentation at ESMO Breast Canc

    2/27/26 8:00:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beamr Issues Annual CEO Letter to Shareholders: From Validation to Execution in AI Video

    In 2026, Beamr plans to build the foundations of its long-term growth by further developing solutions for video data in AI systems - both for human viewers and for machine vision Herzliya, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ:BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer. Dear Shareholders: As we enter 2026, I am pleased to share with you our key achievements last year and update you on our strategy to drive future growth. 2025 was a year of meaningful progress for Beamr as we validated our technology for the autonomous vehicle (AV) sector, strengthened our

    2/26/26 4:10:00 PM ET
    $BMR
    Computer Software: Prepackaged Software
    Technology

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fenech Joseph A. bought $19,830 worth of shares (1,000 units at $19.83), increasing direct ownership by 11% to 10,102 units (SEC Form 4)

    4 - First Internet Bancorp (0001562463) (Issuer)

    2/26/26 11:54:08 AM ET
    $INBK
    Major Banks
    Finance

    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/25/26 9:00:02 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Anderson Mark Lewis bought $9,060 worth of shares (3,000 units at $3.02), increasing direct ownership by 20% to 18,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/19/26 9:00:04 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    SEC Filings

    View All

    SEC Form 10-K filed by CVB Financial Corporation

    10-K - CVB FINANCIAL CORP (0000354647) (Filer)

    2/27/26 5:23:08 PM ET
    $CVBF
    Major Banks
    Finance

    SEC Form S-8 filed by CNS Pharmaceuticals Inc.

    S-8 - CNS Pharmaceuticals, Inc. (0001729427) (Filer)

    2/27/26 5:22:40 PM ET
    $CNSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Westamerica Bancorporation

    10-K - WESTAMERICA BANCORPORATION (0000311094) (Filer)

    2/27/26 5:08:30 PM ET
    $WABC
    Major Banks
    Finance

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Growth Officer Wells Meaghan Danielle was granted 829,327 shares and covered exercise/tax liability with 28,956 shares, increasing direct ownership by 152% to 1,327,052 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:08:28 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Chief Marketing Officer Lauria Kristen was granted 721,154 shares and covered exercise/tax liability with 39,708 shares, increasing direct ownership by 69% to 1,667,177 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:07:29 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Chief Legal Officer Knopf Matthew J. was granted 757,211 shares and covered exercise/tax liability with 35,728 shares, increasing direct ownership by 60% to 1,932,493 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:06:34 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Financials

    Live finance-specific insights

    View All

    ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    - Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains on track following strong 2025 execution; company anticipates multiple meaningful data sets and milestones in the coming 12 to 18 months - - Evorpacept biomarker strategy validated by data from both the Phase 2 ASPEN-06 gastric cancer trial and the Phase 1b/2 breast cancer trial, independently suggesting CD47 overexpression is predictive of evorpacept activity and drives durable benefit in HER2-positive cancers - - Full biomarker analysis from Phase 1b/2 evorpacept-zanidatamab combination trial accepted for poster presentation at ESMO Breast Canc

    2/27/26 8:00:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Satellogic Schedules Fourth Quarter and Full Year 2025 Results Conference Call on Thursday, March 19, 2026 at 8:00 a.m. Eastern Time

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ:SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, will hold a conference call on Thursday, March 19, 2026 at 8:00 a.m. Eastern time to discuss its results for the fourth quarter and fiscal year 2025 ended December 31, 2025, and will be providing updates on recent commercial advancements, partnerships, and other initiatives and milestones. Satellogic's Chief Executive Officer Emiliano Kargieman and Chief Financial Officer Rick Dunn will host the conference call, followed by a question-and-answer period. The conference call will be acco

    2/26/26 8:30:00 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Bed Bath & Beyond, Inc. Reports Eighth Consecutive Quarter of Measurable Improvement Toward Profitability

    Q4 Reflects Strengthening Revenue Trends, Sustained Margin Expansion and a $118 Million Year-Over-Year Improvement in Operating Cash Flow Use Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's Home and a blockchain asset portfolio, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company delivered its eighth consecutive quarter of measurable improvement toward profitability, reflecting continued margin expansion, disciplined cost management and consistent progress across key operating metrics. The Company has successfully built the base of its business through disciplined retail executio

    2/23/26 4:01:00 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:49:27 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:47:57 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:45:55 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Leadership Updates

    Live Leadership Updates

    View All

    Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors

    ST. LOUIS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ:ADV) announced the appointments of Thomas Turner and Xiaofeng "Frank" Yao to its Board of Directors, effective as of February 20, 2026. About Thomas Turner Turner currently serves as Senior Managing Director at CVC Capital Partners (U.S.) Inc., where he has been a member of the Capital Markets team since September 2022. Prior to CVC, Turner held Managing Director roles at Apollo Global Management, Inc. and Bank of America Merrill Lynch, as well as earlier positions at Goldman Sachs and Deutsche Bank. He holds a B.A. from Cornell University and an M.B.A. from New York University's Stern School of Business. Abou

    2/25/26 8:00:00 AM ET
    $ADV
    Real Estate

    MVB Financial Names Dr. Kelly Nelson Chairman of the Board of Directors; Appoints Adam Famularo New Director

    The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") (NASDAQ:MVBF), today announced that Dr. Kelly R. Nelson has been named Chairman of the Board and announced the appointment of Adam Famularo as a Member of the Board, effective February 17, 2026. Dr. Nelson Assumes Chairman Role Dr. Nelson, who has been a member of the Board since 2004, replaces retiring Chairman W. Marston "Marty" Becker. "Dr. Nelson brings a combination of medical expertise, business acumen and deep community commitment to his new role as Chairman," said Larry F. Mazza, CEO and President, MVB Financial. "His experience makes him uniquely suited for this leadership role. Dr. Nelson previously ch

    2/18/26 4:30:00 PM ET
    $MVBF
    Major Banks
    Finance

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care